Literature DB >> 6462572

Adenocarcinoma of the endometrium in women 40 years of age or younger.

D G Gallup, R J Stock.   

Abstract

Excluding cases associated with oral sequential contraceptives, adenocarcinoma of the endometrium in young women is rare, constituting about 3% of endometrial carcinomas. The present report, based on findings from one institution, notes that women 40 years of age or younger comprised 14.4% of the 111 patients with adenocarcinoma of the endometrium. Factors analyzed in patients 40 years of age or younger (group A) as compared with those 41 years of age or older (group B) include the following: obesity 43.8% (A) versus 17.9% (B), nulliparity 44% (A) versus 10.5% (B), hypertension 31.2% (A) versus 42.1% (B), and diabetes 6.2% (A) versus 21.1% (B). Patients in group A tended to have a well-differentiated tumor, and 31.2% had polycystic ovaries. Awareness of risk factors in young women who develop endometrial adenocarcinoma leads to earlier diagnosis and will preserve the historically excellent survival rate of young women.

Entities:  

Mesh:

Year:  1984        PMID: 6462572

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  47 in total

1.  The Futility of Systematic Lymphadenectomy in Early-Stage Low-grade Endometrial Cancer.

Authors:  Nidhi Nayyar; Prerna Lakhwani; Ashish Goel; Pankaj Kr Pande; Kapil Kumar
Journal:  Indian J Surg Oncol       Date:  2018-04-18

2.  Racial disparities in young women with endometrial cancer.

Authors:  Barenya Mukerji; Caitlin Baptiste; Ling Chen; Ana I Tergas; June Y Hou; Cande V Ananth; Alfred I Neugut; Dawn L Hershman; Jason D Wright
Journal:  Gynecol Oncol       Date:  2018-01-05       Impact factor: 5.482

Review 3.  Progesterone receptor action in leiomyoma and endometrial cancer.

Authors:  J Julie Kim; Elizabeth C Sefton; Serdar E Bulun
Journal:  Prog Mol Biol Transl Sci       Date:  2009-10-07       Impact factor: 3.622

Review 4.  Pathophysiology and management of endometrial hyperplasia and carcinoma.

Authors:  Y S Fu; J C Gambone; J S Berek
Journal:  West J Med       Date:  1990-07

5.  A case of endometrial carcinoma progressed during pregnancy resulting in fetal death.

Authors:  Emi Ota; Hidetaka Nomura; Kohei Omatsu; Yutaka Takazawa; Nobuhiro Takeshima
Journal:  Int Cancer Conf J       Date:  2020-05-22

Review 6.  Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases.

Authors:  Mi-La Kim; Seok Ju Seong
Journal:  Obstet Gynecol Sci       Date:  2013-03-12

7.  Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome).

Authors:  Louise A Brinton; Kamran S Moghissi; Carolyn L Westhoff; Emmet J Lamb; Bert Scoccia
Journal:  Fertil Steril       Date:  2009-11-25       Impact factor: 7.329

8.  Successful pregnancy in a patient with endometrial carcinoma treated with medroxyprogesterone acetate.

Authors:  K Niwa; Y Yokoyama; T Tanaka; T Murase; S Morishita; M Itoh; N Itoh; K Shimokawa; T Tamaya
Journal:  Arch Gynecol Obstet       Date:  1994       Impact factor: 2.344

9.  Novel hydroxysteroid (17beta) dehydrogenase 1 inhibitors reverse estrogen-induced endometrial hyperplasia in transgenic mice.

Authors:  Taija Saloniemi; Päivi Järvensivu; Pasi Koskimies; Heli Jokela; Tarja Lamminen; Sadaf Ghaem-Maghami; Roberto Dina; Pauliina Damdimopoulou; Sari Mäkelä; Antti Perheentupa; Harry Kujari; Jan Brosens; Matti Poutanen
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

Review 10.  Malignant tumors of the uterine corpus: molecular background of their origin.

Authors:  D Brany; D Dvorska; M Nachajova; P Slavik; T Burjanivova
Journal:  Tumour Biol       Date:  2015-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.